Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Journal of the National Comprehensive Cancer Network : JNCCN|April 25, 2008
Beyond the guidelines in the treatment of peripheral T-cell lymphoma: new drug developmentAndy I Chen, Ranjana H Advani
American Journal of Ophthalmology Case Reports|June 23, 2025
Macular retinoschisis in a patient with multiple lymphoproliferative malignanciesJustine Cheng, Paul Yang, Andy I Chen, et al.
Leukemia Research Reports|June 13, 2018
Acute promyelocytic leukemia presenting with features of metastatic osseous diseaseCarmen Winters, Andy I Chen, Stephen Moore, et al.
Therapeutic Advances in Hematology|May 6, 2017
Targeting the programmed cell death 1 pathway in Hodgkin lymphoma: the place of nivolumabNathan D Gay, Craig Y Okada, Andy I Chen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 11, 2008
Long-term results of autologous hematopoietic cell transplantation for peripheral T cell lymphoma: the Stanford experienceAndy I Chen, Alex McMillan, Robert S Negrin, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 8, 2023
A phase II trial of netupitant/palonosetron for prevention of chemotherapy-induced nausea/vomiting in patients receiving BEAM prior to hematopoietic cell transplantationJoseph S Bubalo, Jennifer L Radke, Kenneth G Bensch, et al.
Leukemia & Lymphoma|May 24, 2013
Improved outcome with busulfan, melphalan and thiotepa conditioning in autologous hematopoietic stem cell transplant for relapsed/refractory Hodgkin lymphomaTarunpreet Bains, Andy I Chen, Andrew Lemieux, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 23, 2023
Long-term Outcomes After Hematopoietic Cell Transplant in Peripheral T-Cell Lymphoma - The Oregon Health and Science University ExperienceDerek Galligan, Staci Williamson, Jessie Myers, et al.
European Journal of Immunology|October 2, 2002
Costimulatory molecule OX40L is critical for both Th1 and Th2 responses in allergic inflammationRuth S S Arestides, Hongzhen He, Robert M Westlake, et al.
Blood|January 11, 2003
Ligation of OX40 (CD134) regulates graft-versus-host disease (GVHD) and graft rejection in allogeneic bone marrow transplant recipientsBruce R Blazar, Arlene H Sharpe, Andy I Chen, et al.
Pageof 4